Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer

[Image: see text] Prostate cancer (PCa) is the second most common cause of cancer death among American men after lung cancer. Unfortunately, current therapies do not provide effective treatments for patients with advanced, metastatic, or hormone refractory disease. Therefore, we seek to generate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Stacy E., Ganguly, Tanushree, Munske, Gerhard R., Fulton, Melody D., Hopkins, Mark R., Berkman, Clifford E., Black, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198102/
https://www.ncbi.nlm.nih.gov/pubmed/25157916
http://dx.doi.org/10.1021/bc500362n

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198102/
https://www.ncbi.nlm.nih.gov/pubmed/25157916
http://dx.doi.org/10.1021/bc500362n

Ejemplares similares